SG Americas Securities’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.79M | Buy |
308,331
+42
| +0% | +$244 | 0.01% | 748 |
|
|
2025
Q1 | $869K | Sell |
308,289
-9,339
| -3% | -$26.3K | ﹤0.01% | 1157 |
|
|
2024
Q4 | $2.19M | Sell |
317,628
-25,562
| -7% | -$176K | 0.01% | 499 |
|
|
2024
Q3 | $6.24M | Sell |
343,190
-6
| -0% | -$109 | 0.02% | 315 |
|
|
2024
Q2 | $6.52M | Buy |
343,196
+336,196
| +4,803% | +$6.39M | 0.04% | 408 |
|
|
2024
Q1 | $151K | Buy |
7,000
+667
| +11% | +$14.4K | ﹤0.01% | 1959 |
|
|
2023
Q4 | $110K | Buy |
+6,333
| New | +$110K | ﹤0.01% | 2466 |
|
|
2023
Q1 | – | Sell |
-87,987
| Closed | -$1.34M | – | 3134 |
|
|
2022
Q4 | $1.34M | Sell |
87,987
-10,966
| -11% | -$167K | 0.02% | 672 |
|
|
2022
Q3 | $977K | Sell |
98,953
-2,500
| -2% | -$24.7K | 0.01% | 883 |
|
|
2022
Q2 | $1.2M | Buy |
101,453
+8
| +0% | +$95 | 0.01% | 1000 |
|
|
2022
Q1 | $1.93M | Sell |
101,445
-400
| -0.4% | -$7.6K | 0.01% | 812 |
|
|
2021
Q4 | $2.38M | Buy |
101,845
+89,143
| +702% | +$2.09M | 0.01% | 863 |
|
|
2021
Q3 | $275K | Buy |
12,702
+7,300
| +135% | +$158K | ﹤0.01% | 2762 |
|
|
2021
Q2 | $138K | Sell |
5,402
-43
| -0.8% | -$1.1K | ﹤0.01% | 2265 |
|
|
2021
Q1 | $129K | Buy |
+5,445
| New | +$129K | ﹤0.01% | 2686 |
|